ROYCE & ASSOCIATES LP - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 106 filers reported holding HERON THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.05 and the average weighting 0.6%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$852,000
-50.1%
72,6000.0%0.01%
-20.0%
Q4 2019$1,706,000
+31.7%
72,600
+3.7%
0.02%
+25.0%
Q3 2019$1,295,000
-0.5%
70,0000.0%0.01%0.0%
Q2 2019$1,301,000
-24.0%
70,0000.0%0.01%
-14.3%
Q1 2019$1,711,000
-5.8%
70,0000.0%0.01%
-12.5%
Q4 2018$1,816,000
-11.7%
70,000
+7.7%
0.02%
+14.3%
Q3 2018$2,057,000
-18.5%
65,0000.0%0.01%
-17.6%
Q2 2018$2,525,000
+10.9%
65,000
-21.2%
0.02%
+6.2%
Q1 2018$2,277,000
+52.5%
82,5000.0%0.02%
+60.0%
Q4 2017$1,493,000
+37.0%
82,500
+22.2%
0.01%
+42.9%
Q3 2017$1,090,000
+36.9%
67,500
+17.4%
0.01%
+40.0%
Q2 2017$796,000
-7.5%
57,500
-2.8%
0.01%
+66.7%
Q1 2015$861,000
-49.8%
59,147
-65.3%
0.00%
-50.0%
Q4 2014$1,716,000170,5800.01%
Other shareholders

There were no reported owners of HERON THERAPEUTICS INC in Q2 2017.

NameSharesValueWeighting ↓
View complete list of HERON THERAPEUTICS INC shareholders